Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan-Feb;12(1):89-94.
doi: 10.32598/bcn.12.1.1368.1. Epub 2021 Jan 1.

The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis

Mostafa Almasi  1 , Mohammad Ali Sahraian  2 , Fahimeh Haji Akhoundi  1 , Hamid Reza Ezzati  3 , Mohammad Rohani  3
Affiliations

The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis

Mostafa Almasi et al. Basic Clin Neurosci. 2021 Jan-Feb.

Abstract

Introduction: An impaired sense of smell has a remarkable impact on the quality of life. It is seen in a variety of neurodegenerative diseases such as Parkinson disease. In this study, we assessed the olfactory function in patients with Multiple Sclerosis (MS) by Sniff Magnitude Test (SMT).

Methods: A cross-sectional study was conducted on 48 patients with MS. A questionnaire, including demographic and clinical variables, was completed for each patient. The SMT was used for the evaluation of olfactory function.

Results: Olfactory dysfunction was found in 14.6% of patients (8.3% hyposmia and 6.3% anosmia). Older age, longer disease duration, higher hospital admission rate, lower minimental status examination score, and secondary progressive course of MS were significantly related to olfactory dysfunction.

Conclusion: Secondary progressive MS and markers of advanced disease toward neurodegenerative phase (including older age, longer disease duration, and lower cognitive function) can be associated with olfactory dysfunction in MS patients.

Keywords: Anosmia; Multiple Sclerosis; Olfaction disorders; Secondary Progressive Multiple Sclerosis; Smell.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors report no conflict of interest.

Similar articles

See all similar articles

Cited by

  • International consensus statement on allergy and rhinology: Olfaction.
    Patel ZM, Holbrook EH, Turner JH, Adappa ND, Albers MW, Altundag A, Appenzeller S, Costanzo RM, Croy I, Davis GE, Dehgani-Mobaraki P, Doty RL, Duffy VB, Goldstein BJ, Gudis DA, Haehner A, Higgins TS, Hopkins C, Huart C, Hummel T, Jitaroon K, Kern RC, Khanwalkar AR, Kobayashi M, Kondo K, Lane AP, Lechner M, Leopold DA, Levy JM, Marmura MJ, Mclelland L, Miwa T, Moberg PJ, Mueller CA, Nigwekar SU, O'Brien EK, Paunescu TG, Pellegrino R, Philpott C, Pinto JM, Reiter ER, Roalf DR, Rowan NR, Schlosser RJ, Schwob J, Seiden AM, Smith TL, Soler ZM, Sowerby L, Tan BK, Thamboo A, Wrobel B, Yan CH. Patel ZM, et al. Int Forum Allergy Rhinol. 2022 Apr;12(4):327-680. doi: 10.1002/alr.22929. Int Forum Allergy Rhinol. 2022. PMID: 35373533 Free PMC article. Review.

References

    1. Bacon Moore A., Paulsen J. S., Murphy C. (1999). A test of odor fluency in patients with Alzheimer’s and Huntington’s disease. Journal of Clinical and Experimental Neuropsychology, 21(3), 341–51. [DOI:10.1076/jcen.21.3.341.918] [PMID ] - DOI - PubMed
    1. Barresi M., Ciurleo R., Giacoppo S., Cuzzola V. F., Celi D., Bramanti P., et al. (2012). Evaluation of olfactory dysfunction in neurodegenerative diseases. Journal of the Neurological Sciences, 323(1–2), 16–24. [DOI:10.1016/j.jns.2012.08.028] [PMID ] - DOI - PubMed
    1. Barrios F. A., Gonzalez L., Favila R., Alonso M. E., Salgado P. M., Diaz R., et al. (2007). Olfaction and neurodegeneration in HD. Neuroreport, 18(1), 73–6. [DOI:10.1097/WNR.0b013e3280102302] [PMID ] - DOI - PubMed
    1. Brämerson A., Johansson L., Ek L., Nordin S., Bende M. (2004). Prevalence of olfactory dysfunction: The Skövde population-based study. The Laryngoscope, 114(4), 733–7. [DOI:10.1097/00005537-200404000-00026] [PMID ] - DOI - PubMed
    1. Compston A., Coles A. 2002. Multiple Sclerosis. The Lancet, 359(9313), 1221–31. [DOI:10.1016/S0140-6736(02)08220-X] - DOI - PubMed

LinkOut - more resources